Mr. Hector Bremner reports

HEALTHTAB(TM) TO INTEGRATE CONTOUR(TM)NEXT FAMILY OF BLOOD GLUCOSE METERS TO OFFER DEEPER DIABETES PATIENT INSIGHTS

Avricore Health Inc. has signed an agreement with Ascensia Diabetes Care, a global diabetes care company, to integrate its blood glucose monitoring (BGM) systems, marketed as Contour Next Gen and Contour Next One, with Avricore's pharmacy-based point-of-care testing (POCT) platform, HealthTab. Ascensia Diabetes Care is a subsidiary of PHC Holdings Corp.

The partnership's objective is to support patients and pharmacists in Canada in better managing diabetes by linking the daily blood glucose testing results and pattern history data collected via the Contour Next Gen or Contour Next One metre the patient uses to the patient's HealthTab account. The partnership also seeks to support utilization of each technology by opening discussions related to collaborative communications to ensure patients and pharmacists are able to take advantage of what these data insights offer.

"Health data silos are leading to terrible outcomes for patients, but with this collaboration we can ensure patients and their pharmacists have the right information for better care decisions," said Hector Bremner, chief executive officer of Avricore Health. "This is also the first time we are integrating a device that is with the patient and not located in the pharmacy, opening doors for exciting possibilities for HealthTab."

Combining these new daily data insights from the patient's BGM with the results, such as the patient's HbA1c and lipids profile collected during the patient's regular consultations with their pharmacist utilizing HealthTab and its associated instruments, this collaboration will deliver a more robust personal health data tool for the fight against diabetes, which affects one in 10 adults around the world.

"At Ascensia we strive to make diabetes management as simple as possible. We enable people with diabetes, and their caregivers, to use data to make informed decisions with their health care provider. It is important to provide systems that make monitoring easier and well suited to modern-day living," said Annika Pawaroo, head of region Americas, Ascensia Diabetes Care. "This partnership is a vital step in elevating patient care delivery to the next level."

Avricore Health and Ascensia anticipate being able to conclude the technical work and launch the patient interface by Q3 of this year. Continuing work will be done to identify ways to communicate and encourage patient engagement. Both parties look forward to updating on progress as work continues.

About HealthTab

HealthTab is a turnkey point-of-care testing solution that combines best-in-class point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues.

With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data are reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (such as HbA1c, lipid profile, eGFR (estimated glomerular filtration rate)). HealthTab has also recently added capabilities for bacterial and viral tests, such as strep and COVID-19.

The HealthTab network model is unlike anything in pharmacy today. It gives knowledgeable and trusted pharmacists a greater role in primary care delivery, while empowering patients to take more control of their health. It also reduces costs and waiting times and provides many potential revenue streams including equipment leasing and consumables, direct access testing, disease prevention and management programs, sponsored health programs, decentralized clinical trials, real-world data (RWD) sets, and third party app integration through application programming interface.

HealthTab market fast facts:

• Point-of-care testing market to reach $50.6-billion (U.S.) in 2025;
• Glucose monitoring (diabetes related) to make up the largest growth within the sector;
• Nearly 13.6 million Canadians expected to be diabetic or prediabetic by 2030, with many undiagnosed;
• Over one in three Americans, approximately 88 million people, have prediabetes;
• Close to 160,000 Canadians 20 years and older are diagnosed with heart disease each year, often it is only after a heart attack they are diagnosed;
• There are more than 10,000 pharmacies in Canada, 88,000 pharmacies in the United States and nearly 12,000 in the United Kingdom.

About Avricore Health Inc.

Avricore Health is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab (a wholly owned subsidiary), its mission is to make actionable health information more accessible to everyone by creating the world's largest network of rapid testing devices in community pharmacies.

We seek Safe Harbor.